|
|
Great Lakes Pharmaceuticals is a specialty pharmaceutical company that is developing an anti-infective lock solution to address in-dwelling venous catheter mediated infection. The company acquired rights to unique technologies that inhibit formation of biofilms and eradicates established biofilm. The company is planning to initiate a pivotal phase III clinical trial in 2009.
Funders:
North Coast Angel Fund, Ohio Tech Angel Fund, Case Technology Ventures, JumpStart
|
|
|